iRadimed (NASDAQ:IRMD – Get Free Report) and Mettler-Toledo International (NYSE:MTD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for iRadimed and Mettler-Toledo International, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| iRadimed | 0 | 1 | 3 | 1 | 3.00 |
| Mettler-Toledo International | 0 | 6 | 6 | 0 | 2.50 |
iRadimed presently has a consensus target price of $120.00, indicating a potential upside of 30.29%. Mettler-Toledo International has a consensus target price of $1,408.55, indicating a potential upside of 27.51%. Given iRadimed’s stronger consensus rating and higher probable upside, research analysts plainly believe iRadimed is more favorable than Mettler-Toledo International.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| iRadimed | $83.81 million | 14.04 | $22.48 million | $1.83 | 50.33 |
| Mettler-Toledo International | $4.03 billion | 5.54 | $869.19 million | $42.64 | 25.91 |
Mettler-Toledo International has higher revenue and earnings than iRadimed. Mettler-Toledo International is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares iRadimed and Mettler-Toledo International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| iRadimed | 27.36% | 24.48% | 21.25% |
| Mettler-Toledo International | 21.40% | -622.80% | 24.97% |
Insider & Institutional Ownership
92.3% of iRadimed shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 36.8% of iRadimed shares are held by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
iRadimed has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500.
Summary
iRadimed beats Mettler-Toledo International on 8 of the 15 factors compared between the two stocks.
About iRadimed
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
About Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
Receive News & Ratings for iRadimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRadimed and related companies with MarketBeat.com's FREE daily email newsletter.
